← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Stc Biologics, Inc
Cambridge, MA
$4,425,189
Total funding
5
Grants
Funding over time
peak $2.5M · FY2010–17$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,425,189 · 5
By mechanism
N44$2,499,488 · 1
R01$1,318,320 · 1
R43$300,000 · 1
N43$299,881 · 1
N02$7,500 · 1
Investigators at Stc Biologics, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
OTHER FUNCTIONS SBIR PHASE II TOPIC 275, "DEVELOPMENT OF GENERIC TRASTUZUMAB FOR$2,499,488
N44 · FY2012 · CA
The role of IgE in human schistosomiasis$569,904
R01 · FY2016 · AI
The role of IgE in human schistosomiasis$567,308
R01 · FY2015 · AI
A Multi-Targeting Ligand Trap to Overcome resistance in BRAF Mutant Colorectal Cancer$300,000
R43 · FY2015 · CA
TAS::75 0849::TAS THE GOAL OF THIS PROJECT IS TO DEVELOP STC TRASTUZUMAB, A GEN$299,881
N43 · FY2010 · CA
The role of IgE in human schistosomiasis$181,108
R01 · FY2017 · AI
IGF::OT::IGFSTC BIOLOGICS, INC.:1183217 [15-011968]$7,500
N02 · FY2016 · DA